Iris S G Brummelhuis

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Prognostic Factors

Muscle Invasive Bladder Cancer

Top Venues

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Iris S G Brummelhuis, Johannes Crezee, J Alfred Witjes
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 40 (1) (2023)
Iris S G Brummelhuis, Johannes Crezee, J Alfred Witjes
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 40 (1) (2023)
F Johannes P van Valenberg, Iris S G Brummelhuis, Lars Hartwin Lindner, Felix Kuhnle, Barbara Wedmann, Pascal Schweizer, Martin Hossann, J Alfred Witjes, Egbert Oosterwijk
DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer. International journal of nanomedicine 16 (2021)
Iris S G Brummelhuis, Michiel Simons, Lars Hartwin Lindner, Simone Kort, Sytse de Jong, Martin Hossann, J Alfred Witjes, Egbert Oosterwijk
DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 38 (1) (2021)